Sema4A reportedly binds to the Tim2 receptor in the immune system (Kumanogoh et al., 2002; Wilker et al., 2007), and antibodies to Sema4A reduce the severity of neurological symptoms in the experimental autoimmune encephalomyelitis demyelinating animal model. The gene discussed is SEMA4A; the disease is experimental autoimmune encephalomyelitis.